ReviewFrontiers in cardiovascular medicine2025
Neuropsychiatry of atrial fibrillation: dementia and beyond.
Review in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Atrial Fibrillation and Cognitive Decline: Mechanisms, Evidence, and Preventive Strategies-A Narrative Review.Journal of clinical medicine · 2026Review
- The impact of the TyG index and psychosocial factors on depression in elderly non-diabetic patients with atrial fibrillation.Frontiers in psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atrial fibrillation (AF) is the most frequent heart rhythm disorder worldwide with a prevalence of 1%-2% in general population. It is associated with increased mortality and morbidity, including increased risk of dementia. In addition to cognitive impairment, AF has been related to anxiety and mood disorders. Herein we review the literature on the association between AF and neuropsychiatric conditions, including anxiety and mood disorders. The mechanisms underlying the association between AF and dementia are complex, including stroke, chronic cerebral hypoperfusion, and systemic inflammation. There is a bidirectional interaction between AF and anxiety/mood disorders with shared mechanisms involving dysfunction of the autonomic, neuroendocrine and immune systems. Optimizing pharmacological treatment, avoiding drug interactions and implementing behavioral interventions can have a lasting impact on patients with AF undergoing rhythm/rate control therapies and/or catheter ablation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.